The primary efficacy endpoints are the standard deviation and coefficient of determination (R2) between predicted and actual values for the bilirubin regression model, and the grading accuracy for the jaundice severity classification model. The secondary efficacy endpoint is the mean percentage error between predicted and actual bilirubin values. There are no relevant safety risks. Statistical differences for categorical variables (e.g., jaundice grading evaluation indicators) will be analyzed using the chi-square test or Fisher's exact probability test. For continuous variables (e.g., bilirubin prediction evaluation indicators), t-tests (normal distribution) or non-parametric tests (non-normal distribution) will be used. The 95% confidence interval for jaundice grading accuracy will be calculated using the Wilson method. The study duration is estimated to be 3 months.
Study Type
OBSERVATIONAL
Enrollment
270
First Affiliated Hospital of Air Force Military Medical University
Xi'an, Shaanxi, China
RECRUITINGLoss of predicted bilirubin levels
Standard deviation and mean average percentage error between predicted and actual bilirubin levels for the bilirubin regression model.
Time frame: Immediately after test completion
Classification accuracy
Classification accuracy for the jaundice severity grading model
Time frame: Immediately after test completion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.